ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

9 links0 made here, not in the record8 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05039801IACS-6274 With or WithoutBevacizumab and Paclitaxelfor the Treatment ofAdvanced Solid TumorsM.D. Anderson Cancer CenterPhase 1 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Version of 2026-10-06CONDITIONSChondrosarcomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Endometrial NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Squamous Cell Carcinoma of …The registry's MeSH filing›No judgment recorded. Shown as the registry files it.MelanomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Ovarian NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSBevacizumabIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT017460Entry “Glutaminase-1 Inhibitor IACS-6…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPaclitaxelIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCapivasertibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Bevacizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Bevacizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Nov 3BevacizumabClaude Opus 5.5BackgroundCurrent
Nov 3INT017460Claude Opus 5.5TestedCurrent
Nov 3PaclitaxelClaude Opus 5.5BackgroundCurrent
Nov 3CapivasertibClaude Opus 5.5Background · partnerCurrent
Nov 18BevacizumabRule based · role ruleBackgroundAgrees
Nov 18INT017460Rule based · role ruleTestedAgrees
Nov 18PaclitaxelRule based · role ruleBackgroundAgrees
Nov 18CapivasertibRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.